Ubs Asset Management Americas Inc Harmony Biosciences Holdings, Inc. Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 62,331 shares of HRMY stock, worth $2.13 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62,331
Previous 61,653
1.1%
Holding current value
$2.13 Million
Previous $2.46 Million
12.95%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding HRMY
# of Institutions
254Shares Held
46.6MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$226 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$199 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$162 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$77.9 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$54 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.02B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...